An antiviral medication which effectively inhibits replication of the coronavirus causing the COVID-19 and, at the same time, fights the immune reaction that is killing COVID-19 patients around the world.
This is the hope of a group of researchers published new study in the journal Nature Communications. The authors demonstrate that the NRF2 antioxidant gene expression pathway is suppressed in biopsies obtained from COVID-19 patients. The study shows that a drug called dimethyl fumarate (DMF, NRF agonist), which is approved for the treatment of multiple sclerosis patients, inhibits the growth of a range of viruses in the body's cells and that this includes the coronavirus (SARS-CoV2) - at least when the researchers test it in a test tube.
"As we're doing basic research, we obviously don't know whether the drug works on infections in humans, and it's up to the infectious disease experts to test for this. However, I have to say that I'm very optimistic," says the author.
The current research results have been underway for a while now. When the pandemic struck, the authors were in the process of testing the effects of a drug which was virtually identical with a particular sclerosis medicine, namely a substance called 4-octyl-itaconate, which is used on e.g. the herpes virus, smallpox virus (vaccinia virus) and zika virus, and which is also known to lead to foetal defects - all as part of the hunt for a broad spectrum antiviral medication. And their testing succeeded beyond expectations.
"Then the coronavirus suddenly appeared, which we therefore also tested, and saw an enormous effect. The number of duplications that the coronavirus makes of itself in the body's cells were simply drastically reduced," explains the author.
"At the same time, the drug inhibited the immune reaction or inflammatory condition that constitutes a large portion of the actual threat for coronavirus patients. People don't just die of the virus in itself, but also of the inflammation that occurs in the lungs," the author says.
When the research group saw the encouraging results with 4-octyl-itaconate, they repeated the tests with a corresponding approved product, dimethyl fumarate (DMF), which showed virtually the same inhibitory effect.
This means that the effect of dimethyl fumarate (DMF) can be tested on corona patients 'here and now', if clinicians in Denmark or abroad - and the company that holds the patent - are prepared to test it in human trials.
"You can really save a lot of time when you're testing a medication that has already been approved and tested in another context," says the author with reference to the statutory phases involved in getting a medication approved from scratch.
"I'd really likely to be attached to this type of clinical trial if there are infectious disease researchers who assess that the result is worth proceeding with. As a basic researcher, I have neither access to patients, nor am I qualified to conduct clinical testing," the author adds.
https://www.nature.com/articles/s41467-020-18764-3
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fsars-cov2-mediated&filter=22
Multiple sclerosis drug inhibits coronavirus in the lab studies
- 1,364 views
- Added
Edited
Latest News
Human skeletal muscle aging…
By newseditor
Posted 13 May
Disruption of organellar co…
By newseditor
Posted 13 May
Functional heterogeneity of…
By newseditor
Posted 13 May
Gut bacteria produced compo…
By newseditor
Posted 13 May
Role of ECM in brain memory
By newseditor
Posted 13 May
Other Top Stories
Brain Development Analysis in Autism
Read more
A new gene involved in mental disabilities identified
Read more
Iron-containing inflammatory cells in Alzheimer's brains
Read more
A New Pathway of Mitochondria-mediated Cell Death
Read more
Diabetes drug may protect against Parkinson's disease
Read more
Protocols
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
Publications
Human skeletal muscle aging…
By newseditor
Posted 13 May
Accumulation of APP C-termi…
By newseditor
Posted 13 May
Pharmacological induction o…
By newseditor
Posted 13 May
The Effect of Glycine and N…
By newseditor
Posted 13 May
Diindoles produced from com…
By newseditor
Posted 13 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar